文献速递性腺与生殖内分泌垂体与肾上腺疾病

FSH与支持细胞生物标志物可准确区分低促性腺激素性性腺功能减退症与自限性青春期延迟

FSH and Sertoli Cell Biomarkers Accurately Distinguish Hypogonadotropic Hypogonadism From Self-limited Delayed Puberty.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

这项前瞻性巢式病例对照研究纳入65例青春期延迟男性,随访至最终诊断(18岁或睾丸体积达4 mL后≥4年),33例为自限性青春期延迟(SLDP)、32例为先天性低促性腺激素性性腺功能减退症(CHH)。血清FSH、AMH和抑制素B的鉴别诊断效能优于LH和睾酮,FSH×抑制素B<92及FSH×AMH<537对CHH具有高敏感性和特异性。

要点

  • 在青春期延迟男性中,FSH联合抑制素B或AMH对CHH具有高度预测价值。
  • FSH(IU/L)×抑制素B(ng/mL)<92及FSH(IU/L)×AMH(pmol/L)<537对CHH的敏感性>93%、特异性≥92%。
  • 在无预警征象(小阴茎、隐睾和/或小睾丸)的患者中,两组合指标的诊断效能分别为89.7%和88.2%。

核心结论

  • 血清FSH联合抑制素B或AMH在青春期男性中可高度预测并准确区分SLDP与CHH。

研究设计与样本

  • 前瞻性巢式病例对照研究,纳入表现为青春期延迟的男性青少年队列,随访至依据金标准标准(年龄18岁或睾丸体积达4 mL后≥4年)确定最终诊断,比较基线血清生殖激素水平以识别CHH的预测生物标志物。
  • 65例完成随访的参与者中,33例最终诊断为SLDP,32例为CHH。

主要发现

  • 血清FSH、AMH和抑制素B在这些鉴别诊断中的诊断效能优于LH和睾酮。
  • FSH(IU/L)×抑制素B(ng/mL)<92对CHH的敏感性>93%、特异性≥92%、预测值>92%、阳性似然比>12。
  • FSH(IU/L)×AMH(pmol/L)<537对CHH的敏感性>93%、特异性≥92%、预测值>92%、阳性似然比>12。
  • 在无预警征象(小阴茎、隐睾和/或小睾丸)的患者中分析时,FSH×抑制素B和FSH×AMH的诊断效能分别为89.7%和88.2%。

关键数值与推荐

  • FSH(IU/L)×抑制素B(ng/mL)<92对CHH的敏感性>93%、特异性≥92%、预测值>92%、阳性似然比>12。
  • FSH(IU/L)×AMH(pmol/L)<537对CHH的敏感性>93%、特异性≥92%、预测值>92%、阳性似然比>12。
  • 在无预警征象(小阴茎、隐睾和/或小睾丸)的患者中,FSH×抑制素B和FSH×AMH的诊断效能分别为89.7%和88.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Delayed puberty is a frequent complaint in males. The differential diagnosis between self-limited delayed puberty (SLDP) and congenital hypogonadotropic hypogonadism (CHH) is challenging. Commonly used endocrine tests, focusing on stimulated levels of LH or testosterone, are not satisfactory in making a diagnosis. Because FSH action on Sertoli cells results in testis enlargement and anti-Müllerian hormone (AMH) and inhibin B increased secretion, and the FSH-Sertoli cell axis function is detectable during normal childhood and early puberty, we tested whether the assessment of serum FSH, AMH, and inhibin B would be informative to distinguish between SLDP and CHH. DESIGN: We performed a prospective, nested case-control study in a cohort of male adolescents presenting with delayed puberty, comparing baseline serum reproductive hormone levels to identify predictive biomarkers of CHH, after having followed all participants prospectively until a final diagnosis was ascertained based on gold-standard criteria (age 18 years or ≥4 years after testis volume reached 4 mL). RESULTS: Of 65 participants who completed follow-up, 33 had a final diagnosis of SLDP and 32 of CHH. Serum FSH, AMH, and inhibin B showed better diagnostic efficiency than LH and testosterone for these differential diagnoses. FSH (IU/L)×inhibin B (ng/mL) < 92 and FSH (IU/L)×AMH (pmol/L) < 537 showed high sensitivity (>93%), specificity (≥92%), predictive values (>92%), and positive likelihood ratio (>12) for CHH. The diagnostic performance remained 89.7% and 88.2% for FSH × inhibin B and FSH × AMH, respectively, when analyzed in patients without red flags (micropenis, cryptorchidism, and/or microorchidism). CONCLUSION: Serum FSH combined with inhibin B or AMH is highly predictive to accurately distinguish between SLDP and CHH in adolescent males.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Castro S, Correa Brito L, Bedecarrás P, et al. FSH and Sertoli Cell Biomarkers Accurately Distinguish Hypogonadotropic Hypogonadism From Self-limited Delayed Puberty. J Clin Endocrinol Metab. 2025. PMID: 39930628. doi:10.1210/clinem/dgaf062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。